SHOULDER INNOVATIONS, INC. Net Income
SHOULDER INNOVATIONS, INC. (SI) reported Net Income of -$10.15 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Income Statement
us-gaap:NetIncomeLoss · last filed 2026-08-06
- SHOULDER INNOVATIONS, INC. net income (loss) attributable to parent for the quarter ending 2026-06-30 was -$10.15M.
- SHOULDER INNOVATIONS, INC. net income (loss) attributable to parent for the quarter ending 2026-03-31 was -$8.38M.
- SHOULDER INNOVATIONS, INC. net income (loss) attributable to parent for the quarter ending 2025-12-31 was -$7.77M.
- SHOULDER INNOVATIONS, INC. net income (loss) attributable to parent for the quarter ending 2025-09-30 was -$8.73M.
- SHOULDER INNOVATIONS, INC. net income (loss) attributable to parent for fiscal 2025 was -$40.36M.
- SHOULDER INNOVATIONS, INC. net income (loss) attributable to parent for fiscal 2024 was -$15.62M.
| Period end | Net Income (Loss) Attributable to Parent 3 month | Net Income (Loss) Attributable to Parent 6 month | Net Income (Loss) Attributable to Parent 9 month | Net Income (Loss) Attributable to Parent 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$10.15M 10-Q · filed 2026-08-06 | -$18.53M 10-Q · filed 2026-08-06 | -$26.30M derived: sum of 3 quarters · filed 2026-08-06 | -$35.03M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | -$8.38M 10-Q · filed 2026-08-06 | -$16.15M derived: sum of 2 quarters · filed 2026-08-06 | -$24.88M derived: sum of 3 quarters · filed 2026-08-06 | -$44.08M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | -$7.77M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-10 | -$16.50M derived: sum of 2 quarters · filed 2026-03-10 | -$35.70M derived: sum of 3 quarters · filed 2026-08-06 | -$40.36M 10-K · filed 2026-03-10 |
| 2025-09-30 | -$8.73M 10-Q · filed 2025-11-12 | -$27.93M derived: sum of 2 quarters · filed 2026-08-06 | -$32.59M 10-Q · filed 2025-11-12 | -$36.38M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | -$19.20M 10-Q · filed 2026-08-06 | -$23.86M 10-Q · filed 2026-08-06 | -$27.65M derived: sum of 3 quarters · filed 2026-08-06 | -$31.70M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | -$4.66M 10-Q · filed 2026-08-06 | -$8.45M derived: sum of 2 quarters · filed 2026-08-06 | -$12.51M derived: sum of 3 quarters · filed 2026-08-06 | -$16.68M derived: sum of 4 quarters · filed 2026-08-06 |
| 2024-12-31 | -$3.79M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-10 | -$7.85M derived: sum of 2 quarters · filed 2026-03-10 | -$12.02M derived: sum of 3 quarters · filed 2026-03-10 | -$15.62M 10-K · filed 2026-03-10 |
| 2024-09-30 | -$4.05M 10-Q · filed 2025-11-12 | -$8.23M derived: sum of 2 quarters · filed 2025-11-12 | -$11.83M 10-Q · filed 2025-11-12 | |
| 2024-06-30 | -$4.17M 10-Q · filed 2025-11-12 | -$7.77M 10-Q · filed 2025-09-09 | ||
| 2024-03-31 | -$3.60M 10-Q · filed 2025-11-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Orchestra BioMed Holdings, Inc. (OBIO) | United States | $0.356B | -4.39 |
| Orthofix Medical Inc. (OFIX) | $0.373B | ||
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| CARLSMED, INC. (CARL) | United States | $0.405B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |